IRIS
SANGUEDOLCE, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.297
NA - Nord America 3.825
AS - Asia 3.552
SA - Sud America 631
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 11
Totale 12.383
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.735
SG - Singapore 1.406
IE - Irlanda 1.388
CN - Cina 995
SE - Svezia 651
HK - Hong Kong 635
UA - Ucraina 534
BR - Brasile 524
RU - Federazione Russa 477
IT - Italia 432
DE - Germania 222
VN - Vietnam 190
FR - Francia 150
FI - Finlandia 128
IN - India 120
GB - Regno Unito 114
TR - Turchia 70
CA - Canada 46
CZ - Repubblica Ceca 40
AR - Argentina 39
MX - Messico 28
AT - Austria 22
ZA - Sudafrica 22
BD - Bangladesh 21
ES - Italia 21
NL - Olanda 20
ID - Indonesia 19
PL - Polonia 19
BE - Belgio 18
EC - Ecuador 15
CL - Cile 12
IQ - Iraq 12
JP - Giappone 12
VE - Venezuela 12
AU - Australia 11
EU - Europa 11
GR - Grecia 11
AE - Emirati Arabi Uniti 10
LT - Lituania 9
PE - Perù 9
UZ - Uzbekistan 9
CO - Colombia 8
KE - Kenya 8
PY - Paraguay 8
EG - Egitto 7
PK - Pakistan 7
BA - Bosnia-Erzegovina 6
CH - Svizzera 6
CR - Costa Rica 5
IR - Iran 5
LV - Lettonia 5
SA - Arabia Saudita 5
AM - Armenia 4
AZ - Azerbaigian 4
IL - Israele 4
MA - Marocco 4
AL - Albania 3
BG - Bulgaria 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
LB - Libano 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
MG - Madagascar 2
MK - Macedonia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TN - Tunisia 2
TW - Taiwan 2
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CM - Camerun 1
DZ - Algeria 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
JM - Giamaica 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
TH - Thailandia 1
Totale 12.380
Salva come PNG Salva come JPEG
Città #
Dublin 1.387
Singapore 659
Hong Kong 635
Chandler 487
Nyköping 481
Jacksonville 362
Ashburn 355
Dallas 241
Dearborn 222
Beijing 209
New York 207
Santa Clara 207
Nanjing 168
Princeton 142
Munich 113
Moscow 111
Wilmington 91
The Dalles 79
Nanchang 78
Helsinki 66
Los Angeles 64
Ho Chi Minh City 58
São Paulo 57
Shenyang 53
San Mateo 52
Rome 41
Ann Arbor 40
Bari 38
Boardman 38
Hanoi 37
Milan 30
Tianjin 28
Foggia 27
Hebei 27
London 25
Brno 24
Jiaxing 24
Kunming 23
Shanghai 23
Jinan 22
Nuremberg 22
Pune 22
Brooklyn 21
Guangzhou 21
Rio de Janeiro 21
Hangzhou 19
Turku 19
Brussels 18
Changsha 18
Des Moines 18
Seattle 18
Belo Horizonte 16
Chicago 16
San Francisco 16
Warsaw 14
Olomouc 13
Frankfurt am Main 12
Montreal 12
Naples 12
Brasília 11
Falkenstein 11
Haiphong 11
Reading 11
Vienna 11
Zhengzhou 11
Düsseldorf 10
Jakarta 10
Taizhou 10
Tokyo 10
Toronto 10
Washington 10
Boston 9
Council Bluffs 9
Guayaquil 9
Johannesburg 9
Ningbo 9
Norwalk 9
Tashkent 9
Assago 8
Borås 8
Chengdu 8
Denver 8
Phoenix 8
Redwood City 8
Woodbridge 8
Wuhan 8
Atlanta 7
Changchun 7
Chennai 7
Da Nang 7
Genoa 7
Madrid 7
Marousi 7
Orange 7
Ottawa 7
Pescara 7
San Jose 7
Belém 6
Biên Hòa 6
Fuzhou 6
Totale 7.707
Salva come PNG Salva come JPEG
Nome #
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer 203
Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer 195
Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer 186
A recurrent epidermoid cyst of the spleen: report of a case and literature review 157
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 140
Absence of bladder outlet obstruction is an independent risk factor for prostate cancer in men undergoing prostate biopsy 137
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study 136
Un caso di sarcoma di Kaposi viscerale in un paziente con morbo di crohn duodenale e immunodeficienza congenita. 135
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 132
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 129
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 126
Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review 125
A Troubling Diagnosis of Verrucous Squamous Cell Carcinoma ("the Bad Kind" of Keratosis) and the Need of Clinical and Pathological Correlations: A Review of the Literature with a Case Report. 124
Cyclooxygenase isozymes 1 and 2 in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations 124
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 120
Can inspection of the mouth help clinicians diagnose Crohn's disease? A review 117
One stage surgery for synchronous liver metastasis from a neuroendocrine tumor of the colon. A case report 117
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 114
Surgicel (R) granuloma mimicking ovarian cancer: A case report 114
Elderly patients are not at higher risk of urinary incontinence after radical prostatectomy 114
Epigenetic inactivation of the WNT-pathway genes in oral squamous cell carcinoma. Preliminary report 113
Role of age in prostate and bladder cancer. A critical overview 113
A case of ovarian psammocarcinoma associated with endometrioid cysts: a morphological and immunohistochemical study. 112
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 112
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? 111
Epigenetic silencing of wnt-inhibitors: activation of a constitutive wnt signalling in oral cancer 108
Voluminous Omental Inflammatory Myofibroblastic Tumor in an Elderly Man: A Case Report and Literature Review 108
Asymptomatic solitary bladder plasmocytoma: A case report and literature review 108
An unusual delayed complication of paraffin self-injection for penile girth augmentation. 106
A lycopene and olives vegetation water compound improves lower urinary tract symptoms in men with histologically-proven benign prostatic hyperplasia and inflammation 106
Hemoperitoneum due to breaking uterine adenosarcoma located in the omentum. Report of a case 105
The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer 105
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization. 104
Pospho-protein-runx-2 expression is a prognostic marker of metastatic prostate carcinoma. 104
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer 104
Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures 102
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies 101
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 100
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 98
Surgicel® granuloma mimicking ovarian cancer: A case report 97
ARE WE DOING OUR BEST TO PREVENT THE (UNEXPECTED) DISAPPOINTING SIDE EFFECTS OF AN OTHERWISE SUCCESSFUL CANCER TREATMENT? 96
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 96
Multiple Skeletal Muscle Metastases from Colon Carcinoma Preceded by Paraneoplastic Dermatomyositis 96
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 96
Simultaneous radical nephroureterectomy and transurethral distal ureter balloon occlusion and detachment 96
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 93
Cyclooxygenase isozymes in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations. 92
Ectopic manifestation of a cholesterol granuloma in the nasopalatine duct 92
Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm 91
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 90
Epidermoid cyst of the coronal sulcus mimicking penile cancer: a case report. 89
Predictive markers in bladder cancer: Do we have molecular markers ready for clinical use? 89
Daily tadalafil for the chronic phase of stuttering priapism: A case report 89
p-NFkB expression in thyroid cancer. 88
Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review 88
Pilonidal cyst of the penis mimicking carcinoma. 87
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy 87
Magnetic resonance imaging of penile paraffinoma: Case report 86
Detection of novel Human papilloma virus type 82 in laryngeal cancer: case report. 86
Molecular markers in bladder cancer: Novel research frontiers 84
Asymptomatic bladder metastasis from breast cancer. 83
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: A comparison with systematic transrectal ultrasound-guided prostate biopsy 83
Modulation of complement activation by pentraxin-3 in prostate cancer 82
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 82
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer 81
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy 81
N-cadherin up-regulation in aggressive oral squamous cell carcinoma. 80
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy 79
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 78
Prognostic factors for anastomotic urinary leakage following retropubic radical prostatectomy and correlation with voiding outcomes 77
The complex relationship between upper urinary tract and bladder cancer: Clinical and predictive issues 77
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy. 76
Testicular metastasis as the first clinical manifestation of pancreatic adenocarcinoma: A case report 76
Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets 76
Elderly patients and prostate biopsy. How old is too old? 74
Prostate cancer biomarkers: a practical review based on different clinical scenarios 74
SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications 74
Increased expression of the autocrine motility factor is associated with poor prognosis in patients with clear cell-renal cell carcinoma 73
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? 73
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 71
Micropapillary bladder cancer, a variant histology of the elderly 71
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes.  71
Bladder metastasis from lung adenocarcinoma: a difficult differential diagnosis with primary bladder adenocarcinoma. 70
Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer 70
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern 70
Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin 69
Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer 68
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation 67
The broad landscape of follicular lymphoma: Part I 66
Urinary tract large cell neuroendocrine carcinoma: Diagnostic, prognostic and therapeutic issues 65
Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions 64
Liquid Biopsy as a New Tool for Diagnosis and Monitoring in Renal Cell Carcinoma 63
Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review 60
Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception 59
PD-L1 as a prognostic and predictive biomarker in neuroendocrine tumors of the lung: state of the art and future perspectives 59
Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study 59
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis 58
Osseous metaplasia within a urothelial bladder cancer nodal metastasis: a case report. 58
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation 57
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables 57
Totale 9.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021354 0 0 0 0 0 12 91 34 98 99 11 9
2021/2022806 59 12 38 12 45 9 93 60 101 150 27 200
2022/20233.001 262 181 146 107 144 230 10 222 1.532 44 55 68
2023/2024823 83 37 36 20 40 283 72 38 10 23 41 140
2024/20253.205 151 51 131 62 95 360 311 141 795 457 306 345
2025/20262.522 365 442 647 745 298 25 0 0 0 0 0 0
Totale 12.946